6047
1.1. Iminium salts: general procedure (example: 2a)
1,3-dimorpholino 3-phenylpropene (14.4 g, 50 mmol) was dissolved in dry ether (250 ml) and
the resulting solution was cooled at ^5ꢀC. Acetyl chloride (3.9 g, 50 mmol) in dry ether (100 ml)
was slowly added with stirring to the propene solution keeping the temperature at ^5ꢀC during
the addition. Stirring was maintained for 30 min during which the temperature rose to room
temperature. The solid 2a was ®ltered and washed several times with dry ether in order to get rid
of acetmorpholide and was ®nally dried.
ꢀ
0
1
Yield 96%. mp 180 C. H NMR (80 MHz,CD3CN): 2.3±3 (m, 6H, Hb, Hb , Hc), 3.4±3.7 (m,
4H, Ha, Ha0), 7.5±8 (m, 2H, Hb, Hg), 8.7 (d, J=11 Hz, 1H, Ha). IR: 1650 cm^1. Other salts were
prepared from piperidine with XCl (yield 95%, mp 185ꢀC, ꢀ Ha=8.8, J=11 Hz); from morpholine
with XI (yield 95%, mp 210ꢀC, ꢀ Ha=8.7, J=10 Hz); from dimethylamine with XI (yield
95%, mp 194ꢀC, ꢀ Ha=8.8, J=10 Hz).
1.2. ꢁ-Aminophosphonates: general procedure
Iminium salt (5 mmol) in dry acetonitrile (10 ml) was placed in a 50-ml three-necked ¯ask
under dry nitrogen. Freshly distilled trialkylphosphite (5.1 mmol) was then added and the mixture
was stirred overnight. After removal of the solvent, the residue was dissolved in ether (20 ml) and
washed with 2 M HCl (10 ml). The organic layer was washed with further 2 M HCl (3Â5 ml).
The aqueous phase was adjusted at pH 11 with a 5 M NaOH solution and extracted with ether.
The combined organic phases were dried over magnesium sulfate and the solvent was removed to
aord the phosphonate as an oil.
1a: Yield: 40%. MS (EI, 70 eV): m/z 247 (6) M+, 138 (100), M-109. 31P NMR (200 MHz,
CDCl3): 24.2. 1H NMR (200 MHz, CDCl3): 1.34 (m, 2H, Hc), 1.46±1.52 (m, 4H, Hb),1.71(d, 3H,
J=4.6 Hz, CH3 CH), 2.46±2.75 (m, 4H, Ha), 3.30 (dd, J=8, 18 Hz, 1H, CH CH P), 3.67±
3.78 [2d, J=9.33, 9.90 Hz, 6H, P(OCH3)2], 5.63 (m, 2H, CH3 CHCH). 13C NMR (200 MHz,
CDCl3): 18(s), 23.3(s, c), 26.5(s, b, b0), 51.5 (d, J=8.4 Hz, a, a0), 52.5 [d, J=7.3 Hz, (CH3O)2P], 53
[d, J=7.1 Hz, (CH3O)2P], 67.5 (d, J=156.6 Hz, CH CH CH3), 121 (s, CH CH), 132 (d,
J=15.5 Hz, CH3 CH). 1b: Yield: 87%. MS(EI): 269(4), M+, 160 (100), M-109. 31P NMR (200
1
MHz, CDCl3): 23.6; H NMR (200 MHz, CDCl3): 2.5 (s, 6H, N(CH3)2), 3.50 (dd, J=8.8, 17.7
Hz, 1H, CH CH P) 3.75, (d, J=11 Hz, 3H, P(OCH3)2), 3.85 (d, J=11 Hz, 3H, P(OCH3)2),
6.35 (ddd, J=6.7, 9.8, 15 Hz, 1H, CH=CH), 6.7 (dd, J=2.8, 16 Hz, 1H, CH=CH), 7.4 (m, 5H,
C6H5). 13C NMR (200 MHz, CDCl3): 43 [d, J=9.1 Hz, N(CH3)2], 52 (m, P(OCH3)2) 65 (d,
J=159.4 Hz, CH CH P), 120 (s, CHCH), 138 (d, J=15.4 Hz, CHCH), 126, 128, 136 (Ph).
1c: Yield 84%. MS (EI): m/z 339 (4) M+, 202 (100), M-137. 31P NMR (200 MHz, CDCl3): 20.3.
1H NMR (200 MHz, CDCl3): 1.28 [dt, J=6, 16 Hz, 6H, P(OCH2CH3)2], 2.62±2.94 (m, 4H, Ha),
3.45 (dd, J=8, 20 Hz, 1H, CH CH P), 3.66±3.70 (m, 4H, Hb), 4.11 [(m, 4H, P(OCH2CH3)2],
6.20 (dd, J=3, 12, 16 Hz, 1H, Ph CHCH), 6.50 (dd, J=4, 16 Hz, 1H, C6H5 CHCH), 7.20
(m, 5H, C6H5 ). 13C NMR (200 MHz, CDCl3): 18 [m, P(OCH2CH3)2], 52 (d, J=8.2 Hz, a, a0),
62 [2d, J=7 Hz, P(OCH2CH3)2], 65 (d, J=157.9 Hz, CH CH P), 120 (s, C6H5 CHCH),
126, 127, 128, 136 (Ph), 138 (d, J=15 Hz, PhCH). 1d: Yield: 89%, MS (EI): 295 (7) M+, 186
1
(100), M-109. H NMR (200 MHz, CDCl3): 1.72 (m, 4H, Hb), 2.74 (m, 4H, Ha), 3.71 and 3.73
[2d, J=7.31, 6H, P(OCH3)2], 3.59 (dd, J=9.93, 13.4 Hz, 1H, CH CH P), 6.29 (dd, J=4, 6, 16
Hz, 1H, PhCHCH), 6.58 (dd, J=5, 15 Hz, 1H, PhCHCH), 7.32 (m, 5H, Ph).